She presented ocular history of glaucoma under treatment in both eyes and history of breast cancer, treated with letrozole (aromatase inhibitor) and having previously received paclitaxel (taxane) until May 2021, pertuzumab (anti-HER2 antibody) and trastuzumab (anti-HER2 antibody) until May 2022. This evidence concerns the gene ERBB2 and breast carcinoma.